Status:
COMPLETED
Ovarian Blockade During Fertility Preservation in Patients With Endometriosis
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Endometriosis
Eligibility:
FEMALE
18-42 years
Brief Summary
The aim of the study is to demonstrate the non-inferiority of dienogest on the number of mature oocytes collected compared with "conventional" ovarian stimulation protocols (using a GnRH agonist or an...
Detailed Description
Endometriosis is a common pathology affecting 1 in 10 women of childbearing age, and is responsible for around 40% of infertility cases. The impact of endometriosis on fertility has now been clearly ...
Eligibility Criteria
Inclusion
- Patient aged between 18 and 42 inclusive
- Patient with endometriosis
- Patient who has undergone at least one cycle of ovarian stimulation for fertility preservation between June 2022 and September 2023 inclusive, using one of the protocols studied:
- GnRH agonist GnRH antagonist Dienogest
Exclusion
- Non-medical or medical fertility preservation excluding endometriosis
Key Trial Info
Start Date :
December 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 3 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06106919
Start Date
December 18 2023
End Date
April 3 2024
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, France